Seres Therapeutics Inc (MCRB) — Capital Reinvestment Ratio
Latest as of September 2025:
0.00x
Seres Therapeutics Inc (MCRB) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($2.21 Million) in capital expenditures ($8.00K). See MCRB free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$2.21 Million
USD
Capital Expenditures
$8.00K
USD
Data as of
Sep 2025
Most recent filing
Seres Therapeutics Inc Capital Reinvestment Ratio (2016–2025)
This chart tracks Seres Therapeutics Inc's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Seres Therapeutics Inc (2016–2025)
Year-by-year Capital Reinvestment Ratio for Seres Therapeutics Inc from 2016 to 2025. For live market cap and broader valuation context, see Seres Therapeutics Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | $1.12 Million | $252.00K | ▼ -84.2% |
| 2021 | 1.43x | $6.69 Million | $9.57 Million | ▲ +192.3% |
| 2016 | 0.49x | $43.92 Million | $21.49 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow